Graham Capital Management’s Edwards Lifesciences EW Stock Holding History

Graham Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-19,192	Closed	-$1.5M	–	1360
2025 Q2	$1.5M	Buy	19,192 +4,259	+29%	+$318K	0.02%	447
2025 Q1	$1.08M	Buy	+14,933	New	+$1.07M	0.02%	528
2024 Q4	–	Sell	-3,061	Closed	-$202K	–	1302
2024 Q3	$202K	Buy	+3,061	New	+$222K	﹤0.01%	910
2023 Q4	–	Sell	-2,924	Closed	-$203K	–	1084
2023 Q3	$203K	Sell	2,924 -5,081	-63%	-$408K	﹤0.01%	855
2023 Q2	$755K	Buy	+8,005	New	+$696K	0.02%	438
2023 Q1	–	Sell	-12,732	Closed	-$950K	–	1134
2022 Q4	$950K	Sell	12,732 -1,506	-11%	-$116K	0.03%	553
2022 Q3	$1.18M	Buy	+14,238	New	+$1.37M	0.05%	414

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Graham Capital Management's EW Position: Q3 2025 in Review

Graham Capital Management sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 19,192 shares — an estimated $1.5M sold.

Graham Capital Management first reported a position in EW in Q3 2022 and held it in 7 quarters. The position peaked at $1.5M in Q2 2025. 1,255 funds tracked by Wall St. Rank hold EW as of Q3 2025.

Graham Capital Management reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
Graham Capital Management sold 19,192 Edwards Lifesciences shares in Q3 2025, an estimated $1.5M.
Graham Capital Management first reported a position in Edwards Lifesciences in Q3 2022 and held it in 7 quarters.
Graham Capital Management's Edwards Lifesciences position peaked at $1.5M in Q2 2025.
1,255 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Graham Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.